Candida tropicalis: a major pathogen in immunocompromised patients

Area of Science:

• Medical Mycology
• Infectious Diseases
• Hematology

Background:

• Hematologic malignancies and allogeneic bone marrow transplantation (BMT) increase susceptibility to invasive fungal infections.
• Candida species are common causes of opportunistic infections in these high-risk patient populations.
• Understanding the epidemiology and clinical features of Candida infections is crucial for timely diagnosis and treatment.

Purpose of the Study:

• To investigate the species distribution of disseminated Candida infections in patients undergoing treatment for hematologic malignancies or BMT.
• To identify clinical features suggestive of disseminated Candida infections.
• To evaluate the treatment outcomes for patients with disseminated Candida infections.

Main Methods:

• Retrospective analysis of 89 consecutive patients treated for hematologic malignancies or undergoing allogeneic BMT.
• Identification of Candida species from colonized sites and disseminated infections.
• Clinical data collection including patient demographics, infection settings, symptoms, laboratory findings, and treatment outcomes.

Main Results:

• Sixty patients were colonized with Candida albicans and 25 with Candida tropicalis.
• Of 18 disseminated Candida infections, 15 were caused by C. tropicalis and 3 by C. albicans.
• Clinical features suggestive of infection included skin lesions, polyarthralgias/polymyalgias, and renal function deterioration.
• Defervescence occurred in 10/14 treated C. tropicalis infections within 2.5 days, despite persistent granulocytopenia.
• Eight of 15 C. tropicalis infections resolved; four patients died from the infection.

Conclusions:

• Candida tropicalis is a significant cause of disseminated infections in immunocompromised patients, often presenting with distinct clinical features.
• Prompt antifungal therapy can lead to clinical improvement even in granulocytopenic patients.
• Disseminated C. tropicalis infections carry a substantial mortality risk, highlighting the need for early recognition and effective management.